Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy.

International Journal of Antimicrobial Agents
Aditi AiyerTheerthankar Das

Abstract

Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). The resulting chloride and bicarbonate imbalance produces a thick, static lung mucus. This mucus is not easily expelled from the lung and can be colonised by bacteria, leading to biofilm formation. CF lung infection with Burkholderia cepacia complex (BCC), particularly the subspecies B. cenocepacia, results in higher morbidity and mortality. Patients infected with BCC can rapidly progress to "cepacia syndrome", a fatal necrotising pneumonia. The aim of this study was to identify whether a combination therapy (CT) of selected antioxidants and antibiotics significantly disrupts B. cenocepacia biofilms and to determine the optimum CT level for treatment. Using controlled in vitro spectrophotometry, colony-forming unit and microscopy assays, three antioxidants (N-acetylcysteine [NAC], glutathione and vitamin C) and three antibiotics (ciprofloxacin, ceftazidime and tobramycin) were screened and assessed for their ability to disrupt the early and mature biofilms of six B. cenocepacia CF isolates. A combination of NAC and ciprofloxacin produced a statistically significant biofilm disruption in all strains tested, wi...Continue Reading

References

Dec 1, 1993·Journal of Applied Physiology·J H RoumR G Crystal
Jul 23, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yunxia Q O'MalleyBradley E Britigan
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Horst FischerBeate Illek
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A Pankey, L D Sabath
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Kang ChenYunn-Hwen Gan
Jan 18, 2006·British Journal of Biomedical Science·J E MooreJ S Elborn
Dec 1, 2007·Nucleic Acids Research·David S WishartMurtaza Hassanali
Dec 15, 2007·BMJ : British Medical Journal·Jane C DaviesAndrew Bush
Sep 3, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Anthony De SoyzaPaul A Corris
Jan 11, 2012·Current Pharmaceutical Design·Felix Ratjen, Hartmut Grasemann
Mar 25, 2014·The European Respiratory Journal·Anthony J KettleUNKNOWN AREST CF
Feb 27, 2015·Science Translational Medicine·Shaopeng YuanJohn V Fahy
Oct 28, 2015·Antimicrobial Agents and Chemotherapy·Sarah KennedyValerie Waters
May 4, 2016·Lancet·J Stuart Elborn
Dec 3, 2016·Journal of Visualized Experiments : JoVE·Jacob O'BrienChun Peng
Dec 7, 2016·BMC Pulmonary Medicine·Anjali Y BhagirathKangmin Duan
Mar 30, 2017·Nutrients·Harri Hemilä
Dec 6, 2017·Antimicrobial Resistance and Infection Control·Omar M El-HalfawyMiguel A Valvano
Dec 28, 2017·Respiratory Care·Bruce K Rubin
Mar 6, 2018·The Journal of Antimicrobial Chemotherapy·Ilyas AlavKhondaker Miraz Rahman
May 11, 2018·Free Radical Research·Giancarlo AldiniFrancesco Sergio
Feb 6, 2019·Annals of Clinical Microbiology and Antimicrobials·Naveen Kumar Devanga Ragupathi, Balaji Veeraraghavan
Mar 27, 2019·Physical Biology·Vernita GordonKristin Kovach
Oct 28, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nashrawan LababidiMarc Schneider

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.